Search Details

Word: researchers (lookup in dictionary) (lookup stats)
Dates: during 1980-1989
Sort By: most recent first (reverse)


Usage:

Although Wechsler and Mary Rohman, research associate at the Medical Foundation, Inc., conducted the study eight years ago, Wechsler says that more recent research indicates that the numbers have remained relatively unchanged...

Author: By Chip Cummins, | Title: Alcohol Use Now Leads to Problems Later | 5/12/1989 | See Source »

Even if Pons and Fleischmann should turn out to be right, the world's energy problems are not necessarily over. As the proponents of more conventional fusion research have learned, transforming a reaction from a laboratory curiosity to a full-scale energy technology can be incredibly difficult. Magnetic fusion has yet to achieve break-even, the stage at which the amount of energy coming out is equal to that going in. Says Harold Furth, director of Princeton's effort: "We are essentially within a factor of two of break-even now. Seeing that it used to be a factor...

Author: /time Magazine | Title: Science: Fusion Illusion? | 5/8/1989 | See Source »

Confronted by the high cost of research, expiring patents and the explosive growth of generic drugs, many pharmaceutical companies will step up efforts to broaden their global reach through mergers or cooperative ventures. But such pressures were few in 1896, when Hoffmann-La Roche was formed in Basel and began producing a cough syrup called Sirolin. The company prospered at first but then almost went broke during World War I because one of its important markets was revolution-torn Russia. Fearing a Nazi invasion in the 1930s, Hoffmann-La Roche created a twin Canadian-based company called Sapac...

Author: /time Magazine | Title: Just What the Doctor Ordered | 5/8/1989 | See Source »

...years ago, the Sacher family called in Gerber, who headed the Zurich Insurance Co., to take over Hoffmann-La Roche, whose Valium profits had tranquilized it into lethargy. He streamlined the administration, production and research and set out to find a new generation of superstar drugs. The antibiotic Rocephin, which had worldwide sales last year of $445 million, is currently the firm's largest-selling product. Valium, though, remains the second-best seller. Last week the company reported that 1988 profits had risen to $389 million, up 33% from the previous year, on sales of $5.3 billion. Now that Hoffmann...

Author: /time Magazine | Title: Just What the Doctor Ordered | 5/8/1989 | See Source »

...CHIEF OF RESEARCH: Betty Satterwhite Sutter...

Author: /time Magazine | Title: Time Magazine Masthead Vol. 133 No. 19 MAY 8, 1989 | 5/8/1989 | See Source »

Previous | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | Next